Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 3Withdrawn 1Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Observational 9Interventional 3

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Lymphoid 1

Conditions

Sarcoma 1Neoplasm, Residual 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × High-Throughput Nucleotide Sequencing × Clear all
NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
603 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT02339805 2017-07-07

LymphoSeq

Centre Henri Becquerel

Phase NA Completed
30 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Neoplasm, Residual

NCT02420405 2017-02-16

Mutation Detection of EBUS-TBNA Specimens Using NGS

Shanghai Chest Hospital

Phase NA Completed
78 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡